Interplay between HMGA and TP53 in cell cycle control along tumor progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interplay between HMGA and TP53 in cell cycle control along tumor progression
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-13
DOI
10.1007/s00018-020-03634-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells
- (2020) Silvia Parisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HMGA Genes and Proteins in Development and Evolution
- (2020) Robert Vignali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion
- (2020) Gloria Ros et al. Frontiers in Oncology
- HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas
- (2020) Marco De Martino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
- (2019) Xiaoxiang Chen et al. Cell Death & Disease
- EZH2 Confers Sensitivity of Breast Cancer Cells to Taxol by Attenuating p21 Expression Epigenetically
- (2019) Xin Mu et al. DNA AND CELL BIOLOGY
- Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth
- (2019) Kang Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins
- (2019) Daniela D’Angelo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial‐mesenchymal transition of bladder cancer via directly acting on miR‐17‐5p/metalloproteinases 3 axis
- (2019) Hao Peng et al. MOLECULAR CARCINOGENESIS
- The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression
- (2019) Jian-Hong Zhong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression
- (2019) X.P. Cao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LINC01140 Alleviates the Oxidized Low-Density Lipoprotein-Induced Inflammatory Response in Macrophages via Suppressing miR-23b
- (2019) Liping He et al. INFLAMMATION
- SNHG16 as the miRNA let‐7b‐5p sponge facilitates the G2/M and epithelial‐mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma
- (2019) Shengguang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition
- (2019) Cristina Oliveira-Mateos et al. Nature Communications
- SNHG16: A Novel Long-Non Coding RNA in Human Cancers
- (2019) Ming Yang et al. OncoTargets and Therapy
- Long Intergenic Non-Coding RNA 01121 Promotes Breast Cancer Cell Proliferation, Migration, and Invasion via the miR-150-5p/HMGA2 Axis
- (2019) Zhuolu Wang et al. Cancer Management and Research
- RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR
- (2019) Daniela D’Angelo et al. ONCOLOGY RESEARCH
- Modulation of Protein-Interaction States through the Cell Cycle
- (2018) Lingyun Dai et al. CELL
- HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis
- (2018) Monica Fedele et al. CELL CYCLE
- The tumor suppressor protein p53 and the ferroptosis network
- (2018) Rui Kang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs
- (2018) Martha L. Slattery et al. GENOMICS
- HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer
- (2018) Fangfang Fu et al. Cell Death & Disease
- APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
- (2018) Qiang Zhang et al. Cell Death & Disease
- Role of p53 circuitry in tumorigenesis: A brief review
- (2018) Sarfaraj Niazi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53
- (2018) Yuhong Wang et al. JOURNAL OF PATHOLOGY
- Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer
- (2018) Paola Bonetti et al. ONCOGENE
- Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity
- (2018) Paulo Thiago de Souza-Santos et al. Translational Oncology
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Essential role for centromeric factors following p53 loss and oncogenic transformation
- (2017) Dan Filipescu et al. GENES & DEVELOPMENT
- Redundant and incoherent regulations of multiple phenotypes suggest microRNAs’ role in stability control
- (2017) Zhongqi Liufu et al. GENOME RESEARCH
- Cell-Cycle Therapeutics Come of Age
- (2017) Matthew Ingham et al. JOURNAL OF CLINICAL ONCOLOGY
- The cell cycle checkpoint inhibitors in the treatment of leukemias
- (2017) A. Ghelli Luserna di Rora’ et al. Journal of Hematology & Oncology
- The most popular genes in the human genome
- (2017) NATURE
- Chromatin dynamics during the cell cycle at centromeres
- (2017) Sebastian Müller et al. NATURE REVIEWS GENETICS
- Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy
- (2017) Patrick Wolter et al. Oncotarget
- Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content
- (2017) Daniele F Colombo et al. PLoS Genetics
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
- (2016) Gabriel Schmid et al. BMC CANCER
- p53-dependent up-regulation ofCDKN1Aand down-regulation ofCCNE2in response to beryllium
- (2016) P. Gorjala et al. CELL PROLIFERATION
- Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression
- (2016) Laura C. Funk et al. DEVELOPMENTAL CELL
- Targeting mutant p53 in cancer: a long road to precision therapy
- (2016) Fiamma Mantovani et al. FEBS Journal
- Genomic landscape of retinoblastoma inRb−/−p130−/−mice resembles human retinoblastoma
- (2016) Irsan E. Kooi et al. GENES CHROMOSOMES & CANCER
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
- (2016) Liacine Bouaoun et al. HUMAN MUTATION
- Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- HMGA1-pseudogenes and cancer
- (2016) Marco De Martino et al. Oncotarget
- Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis
- (2015) Chantal Bou-Hanna et al. CANCER LETTERS
- Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy
- (2015) Lei Dong et al. CHINESE MEDICAL JOURNAL
- p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
- (2015) C J Blume et al. LEUKEMIA
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
- (2015) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Centrosome dynamics as a source of chromosomal instability
- (2015) Hyun-Ja Nam et al. TRENDS IN CELL BIOLOGY
- Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes
- (2015) Giovanna Maria Pierantoni et al. Oncotarget
- Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
- (2015) Martin Fischer et al. Oncotarget
- A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness
- (2015) Silvia Pegoraro et al. Oncotarget
- HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels
- (2015) Francesca Puca et al. Oncotarget
- HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
- (2015) Francesco Esposito et al. Oncotarget
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- p53 as a target for the treatment of cancer
- (2014) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Understanding the non-canonical pathways involved in p53-mediated tumor suppression
- (2014) K. M. Hager et al. CARCINOGENESIS
- The transcription factor p53: Not a repressor, solely an activator
- (2014) Martin Fischer et al. CELL CYCLE
- The high mobility group A1 molecular switch: turning on cancer – can we turn it off?
- (2014) Tait H Huso et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- miR-23b and miR-130b expression is downregulated in pituitary adenomas
- (2014) Vincenza Leone et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Identification of genomic alterations in oesophageal squamous cell cancer
- (2014) Yongmei Song et al. NATURE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype
- (2014) A. Federico et al. Biology Open
- Identification of potential synthetic lethal genes to p53 using a computational biology approach
- (2013) Xiaosheng Wang et al. BMC Medical Genomics
- Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons
- (2013) C. Brochier et al. JOURNAL OF NEUROSCIENCE
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- The mutant p53 mouse as a pre-clinical model
- (2013) J G Jackson et al. ONCOGENE
- p53 can repress transcription of cell cycle genes through a p21WAF1/CIP1-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements
- (2012) Marianne Quaas et al. CELL CYCLE
- GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability
- (2012) P. Wolter et al. JOURNAL OF CELL SCIENCE
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- CBX7 is a tumor suppressor in mice and humans
- (2012) Floriana Forzati et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells
- (2012) Yang Xi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Regulation of let-7 and its target oncogenes (Review)
- (2012) XIRUI WANG et al. Oncology Letters
- HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis
- (2011) Andrew Schuldenfrei et al. BMC GENOMICS
- miRNA signature associated with outcome of gastric cancer patients following chemotherapy
- (2011) Chang Hee Kim et al. BMC Medical Genomics
- Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
- (2011) X. Wang et al. CLINICAL CANCER RESEARCH
- Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation
- (2011) Yongxing Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators
- (2011) H. Zhu et al. MOLECULAR CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling
- (2011) Ashish Lal et al. PLoS Genetics
- The impact of acetylation and deacetylation on the p53 pathway
- (2011) Christopher L. Brooks et al. Protein & Cell
- HMG modifications and nuclear function
- (2010) Qingchun Zhang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models
- (2010) D. K. Broz et al. CARCINOGENESIS
- Autophagy regulation by p53
- (2010) Maria Chiara Maiuri et al. CURRENT OPINION IN CELL BIOLOGY
- Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
- (2010) Sarah L. Thompson et al. JOURNAL OF CELL BIOLOGY
- Role of the high mobility group A proteins in the regulation of pituitary cell cycle
- (2010) Monica Fedele et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells
- (2009) M. Mannefeld et al. CANCER RESEARCH
- Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice
- (2009) C. V. Rao et al. CARCINOGENESIS
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
- (2009) N R Christoffersen et al. CELL DEATH AND DIFFERENTIATION
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription
- (2009) Gerd A. Müller et al. FEBS Journal
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
- (2008) Qing Ji et al. BMC CANCER
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started